Farhood Alamdari

963 total citations
29 papers, 669 citations indexed

About

Farhood Alamdari is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Farhood Alamdari has authored 29 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Farhood Alamdari's work include Bladder and Urothelial Cancer Treatments (15 papers), Renal cell carcinoma treatment (11 papers) and Urinary and Genital Oncology Studies (9 papers). Farhood Alamdari is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Renal cell carcinoma treatment (11 papers) and Urinary and Genital Oncology Studies (9 papers). Farhood Alamdari collaborates with scholars based in Sweden, Iran and Australia. Farhood Alamdari's co-authors include Börje Ljungberg, Roos, Roger Stenling, Amir Sherif, Ola Winqvist, Göran Landberg, B Holmström, Robert Rosenblatt, Ciputra Adijaya Hartana and Firas Aljabery and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Farhood Alamdari

27 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhood Alamdari Sweden 13 431 355 232 174 162 29 669
Pei Dong China 16 276 0.6× 313 0.9× 214 0.9× 157 0.9× 176 1.1× 60 666
Fabio A. Schutz United States 11 381 0.9× 263 0.7× 177 0.8× 299 1.7× 136 0.8× 30 685
Ilya Tsimafeyeu Russia 15 360 0.8× 325 0.9× 85 0.4× 216 1.2× 143 0.9× 111 628
Junzhou Wu China 15 176 0.4× 201 0.6× 167 0.7× 321 1.8× 133 0.8× 30 645
Valentina Guadalupi Italy 14 385 0.9× 297 0.8× 194 0.8× 225 1.3× 180 1.1× 45 637
I. Alex Bowman United States 14 423 1.0× 206 0.6× 164 0.7× 235 1.4× 141 0.9× 40 610
Ben Andrews United States 6 331 0.8× 213 0.6× 145 0.6× 270 1.6× 231 1.4× 7 685
T Wandert Germany 9 510 1.2× 272 0.8× 190 0.8× 383 2.2× 212 1.3× 9 744
K Miwa Japan 18 426 1.0× 178 0.5× 276 1.2× 285 1.6× 164 1.0× 44 866
Shaan Dudani Canada 14 536 1.2× 271 0.8× 141 0.6× 420 2.4× 246 1.5× 48 765

Countries citing papers authored by Farhood Alamdari

Since Specialization
Citations

This map shows the geographic impact of Farhood Alamdari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhood Alamdari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhood Alamdari more than expected).

Fields of papers citing papers by Farhood Alamdari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhood Alamdari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhood Alamdari. The network helps show where Farhood Alamdari may publish in the future.

Co-authorship network of co-authors of Farhood Alamdari

This figure shows the co-authorship network connecting the top 25 collaborators of Farhood Alamdari. A scholar is included among the top collaborators of Farhood Alamdari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhood Alamdari. Farhood Alamdari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aali, Amirali, Erfan Taherifard, Farhood Alamdari, et al.. (2025). The Effect of Zataria multiflora on Clinical, Pulmonary Function, and Oxidant Factors in Patients With Pulmonary Diseases: A Meta‐Analysis of Clinical Trials. Health Science Reports. 8(5). e70772–e70772.
2.
Alamdari, Farhood, et al.. (2025). Early experience of prostate artery embolization: a retrospective single-centre study. Scandinavian Journal of Urology. 60. 1–7.
3.
Sych, Taras, André Görgens, Loïc Steiner, et al.. (2025). Imaging Single Particle Profiler to Study Nanoscale Bioparticles Using Conventional Confocal Microscopy. Nano Letters. 25(6). 2173–2180. 1 indexed citations
4.
Steiner, Loïc, Maria Eldh, Rosanne E. Veerman, et al.. (2024). Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer. Cancer Letters. 609. 217352–217352. 5 indexed citations
5.
Chabok, Abbas, et al.. (2024). Diagnostic accuracy and safety of renal tumour biopsy in patients with small renal masses and its impact on treatment decisions. Scandinavian Journal of Urology. 59. 141–146. 1 indexed citations
6.
7.
Erlandsson, Ann, Marie Lundholm, Johan Watz, et al.. (2023). Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy. International Journal of Immunopathology and Pharmacology. 37. 1200378121–1200378121. 4 indexed citations
8.
Zirakzadeh, A. Ali, Martin Selinger, Johan Henriksson, et al.. (2023). Immune-Activated B Cells Are Dominant in Prostate Cancer. Cancers. 15(3). 920–920. 13 indexed citations
9.
10.
Alamdari, Farhood, et al.. (2022). Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer—a Swedish retrospective multicentre study of a clinical database. Translational Andrology and Urology. 11(8). 1105–1115. 9 indexed citations
11.
12.
Johansson, Mattias, Farhood Alamdari, Firas Aljabery, et al.. (2021). Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer has no value for treatment decisions and low correlation with nodal status. Scandinavian Journal of Urology. 55(6). 455–460. 3 indexed citations
13.
Eldh, Maria, Michael Mints, Stefanie Hiltbrunner, et al.. (2021). Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour. Cancers. 13(13). 3242–3242. 16 indexed citations
14.
Hiltbrunner, Stefanie, Michael Mints, Maria Eldh, et al.. (2020). Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging. Scientific Reports. 10(1). 5960–5960. 43 indexed citations
15.
Rosenblatt, Robert, Farhood Alamdari, B Holmström, et al.. (2019). Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy. World Journal of Urology. 38(9). 2207–2213. 8 indexed citations
16.
Winerdal, Malin E., David H. Krantz, Ciputra Adijaya Hartana, et al.. (2018). Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness. Cancer Immunology Research. 6(5). 528–538. 52 indexed citations
17.
Hartana, Ciputra Adijaya, Emma Ahlén Bergman, A. Ali Zirakzadeh, et al.. (2018). Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway. PLoS ONE. 13(7). e0200079–e0200079. 19 indexed citations
18.
Rosenblatt, Robert, Farhood Alamdari, B Holmström, et al.. (2016). Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report. World Journal of Urology. 35(6). 921–927. 14 indexed citations
19.
Alamdari, Farhood, Torgny Rasmuson, Kjell Grankvist, & Börje Ljungberg. (2006). Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 41(1). 5–9. 10 indexed citations
20.
Ljungberg, Börje, Göran Landberg, & Farhood Alamdari. (2000). Factors of Importance for Prediction of Survival in Patients with Metastatic Renal Cell Carcinoma, Treated with or without Nephrectomy. Scandinavian Journal of Urology and Nephrology. 34(4). 246–251. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei Dong Breakdown of academic impact, for papers by Fabio A. Schutz Breakdown of academic impact, for papers by Ilya Tsimafeyeu Breakdown of academic impact, for papers by Junzhou Wu Breakdown of academic impact, for papers by Valentina Guadalupi Breakdown of academic impact, for papers by I. Alex Bowman Breakdown of academic impact, for papers by Ben Andrews Breakdown of academic impact, for papers by T Wandert Breakdown of academic impact, for papers by K Miwa Breakdown of academic impact, for papers by Shaan Dudani
Rankless by CCL
2026